The FDA has approved Leqembi Iqlik, a subcutaneous, autoinjector formulation for maintenance dosing in people with early Alzheimer's disease ...

The U.S. Food and Drug Administration (FDA) has approved Leqembi Iqlik (lecanemab-irmb), an under-the-skin autoinjector formulation for maintenance dosing in early Alzheimer’s disease. The approval, ...

September is World Alzheimer’s Month, and the global Alzheimer’s disease community is looking to raise awareness and combat ...

What is Aduhelm for Alzheimer’s? Aduhelm (aducanumab) is an antibody that targets amyloid-beta, the protein that builds up inside nerve cells in those with Alzheimer’s disease. The treatment was ...

The U.S. Food and Drug Administration (FDA) has approved a more gradual titration dosing schedule for Kisunla (donanemab) for people with early symptomatic Alzheimer’s disease based on evidence that ...

The U.S. Food and Drug Administration (FDA) has approved monthly maintenance dosing for Leqembi (lecanemab), a treatment for early Alzheimer’s disease. “The approval of once every four-week ...

Being started on a smaller dose of the approved early Alzheimer’s disease therapy Kisunla (donanemab) — by shifting one vial from the first to the third infusion treatment — reduces the risk of ARIA-E ...

Foralumab, an investigational nasal spray being developed by Tiziana Life Sciences, has been cleared by the U.S. Food and Drug Administration (FDA) for expanded use to treat moderate Alzheimer’s ...

If you have a loved one who’s been diagnosed with Alzheimer’s disease, what’s the chance that they’ll walk away from the safety of their home? According to the Alzheimer’s Association, anyone with ...

Treatment for two years with oral ALZ-801 (valiltramiprosate) sustained cognition and lowered levels of disease-related biomarkers in people with early Alzheimer’s disease carrying one or two copies ...

Anavex Life Sciences’ investigational oral therapy Anavex 2-73 (blarcamesine) significantly slows cognitive and functional decline in people with early Alzheimer’s disease, according to a new data ...